Publicacións en colaboración con investigadores/as de University of Illinois at Chicago (6)

2024

  1. Effect of sodium–glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial

    The Lancet Diabetes and Endocrinology, Vol. 12, Núm. 10, pp. 725-734

2005

  1. Consensus statement: Medical management of acromegaly

    European Journal of Endocrinology, Vol. 153, Núm. 6, pp. 737-740

2003

  1. Diagnosis and treatment of acromegaly complications

    Journal of Endocrinological Investigation, Vol. 26, Núm. 12, pp. 1242-1247

2002

  1. Consensus: Guidelines for acromegaly management

    Journal of Clinical Endocrinology and Metabolism

2000

  1. Criteria for cure of acromegaly: A consensus statement

    Journal of Clinical Endocrinology and Metabolism, Vol. 85, Núm. 2, pp. 526-529

1999

  1. Role of growth hormone (GH)-releasing hormone and somatostatin on leptin-induced GH secretion

    Neuroendocrinology, Vol. 69, Núm. 1, pp. 3-10